Alyeska Investment Group, L.p.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
492
Total Value
25057785470
Accession Number
0001172661-25-002312
Form Type
13F-HR
Manager Name
Alyeska Investment Group, L.p.
Data Enrichment
96% identified
470 identified22 unidentified

Holdings

492 positions
Manager:
Search and click to pin securities to the top
Page 25 of 25
ROKU, INC
Shares:
4281
Value:
$301.6M
Artiva Biotherapeutics, Inc.
Shares:
100000(+0.0%)
Value:
$300.0M(-70.2%)
Akebia Therapeutics, Inc.
Shares:
134277
Value:
$257.8M
Werewolf Therapeutics, Inc.
Shares:
235705(+0.0%)
Value:
$229.2M(-34.3%)
Nautilus Biotechnology, Inc.
Shares:
253468(+0.0%)
Value:
$218.2M(-48.7%)
G01558116
Shares:
20757
Value:
$212.8M
Septerna, Inc.
Shares:
35000(+0.0%)
Value:
$202.7M(-74.7%)
ROCKET PHARMACEUTICALS, INC.
Shares:
30312(+0.0%)
Value:
$202.2M(-46.9%)
Traws Pharma, Inc.
Shares:
52630(-54.9%)
Value:
$121.0M(-88.3%)
Surrozen, Inc./DE
Shares:
10188(+0.0%)
Value:
$118.8M(-18.7%)
B5950S113
Shares:
70293(-93.0%)
Value:
$99.8M(-95.8%)
InflaRx N.V.
Shares:
13538
Value:
$13.8M